Dr Lo joined Hong Kong Genome Institute (HKGI) as the Chief Executive Officer in March 2021. As the CEO, Dr Lo leads HKGI in formulating its strategic direction and development plan. He also provides leadership to the team in launching the Hong Kong Genome Project, the city’s first-ever large-scale whole genome sequencing initiative. With the aspiration to benefit the wider community, Dr Lo drives the team to be the change agent in fostering clinical application of genomic medicine and its long-term development in Hong Kong.
Dr Lo is a seasoned professional in public health and administrative medicine, bringing with him a wealth of knowledge in public healthcare system, service provision and relevant policies. He also has a strong blend of experience in corporate affairs, strategic planning, talent development, research and so on. Prior to his current role, Dr Lo had served in the Hospital Authority (HA) for over 20 years during which he had held various senior management positions, including Director of Strategy & Planning in the HA Head Office and Cluster Chief Executive of the New Territories East Cluster.
In addition to his extensive experience with the HA, Dr Lo also held a number of senior positions both locally and overseas. These included being the Head of Research Office in the former Food and Health Bureau (currently the Health Bureau) of the HKSAR Government, and the Director of Purchasing (Specialist Care Services) with the Cardiff Health Authority of the National Health Service in the United Kingdom.
Professionally, Dr Lo is a practitioner in Public Health & Administrative Medicine. He had served as a Part I and II examiner of the Faculty of Public Health, and Censor and examiner of the Royal Australasian College of Medical Administrators.